All Stories

  1. Mapping of Lipidome Profile in Drug-Resistant Clinical Isolates of Mycobacterium tuberculosis Through Quali-Quantitative Liquid Chromatography-Mass Spectrometry Identifies Signature Lipids
  2. Are microsporidia infections really increasing in HIV/AIDS patients or is it increased awareness?
  3. Cervico-uterine cancer in India: A persistent concern for the medical fraternity, policymakers, and society
  4. Publication-equivalence: Conceptually sound but practically challenging
  5. Harnessing antigenic proteins of Toxoplasma gondii for efficient diagnosis: a study of promising candidates
  6. Reliable, accessible, cost-effective, & easy (RACE) diagnostic modality: A key for elimination of tuberculosis
  7. Biomarkers in health and diseases
  8. Computational identification of dual COX-1 and NIK inhibitors from marine microalga Chlorella vulgaris
  9. Mapping antimicrobial susceptibility of community-acquired uropathogenic Escherichia coli across low, middle and high-income countries highlights significant differences: insights for empiric treatment
  10. Genetic Characterization of Mycobacterium Tuberculosis Isolated from Captive Zoo Animals
  11. Can smoking reduce the incidence and prevalence of non-tuberculous mycobacterial pulmonary disease?
  12. Emergence of new infections and new technologies: Challenges and opportunities
  13. Public–private partnership to end tuberculosis: challenges and opportunities
  14. Tuberculosis preventive treatment in India: Is budget allocation for tuberculosis elimination sufficient?
  15. Diagnostic yield of Xpert MTB/RIF, Xpert MTB/RIF Ultra, and Truenat MTB assays on non-pulmonary samples from suspected cases of extra-pulmonary tuberculosis (EPTB)
  16. Proteomics Analysis and Sequential Events During the in-vivo Acquisition of Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis
  17. An Ideal Point-of-Care Test for Screening Tuberculosis Infection
  18. Prevalence of non-tuberculous mycobacteria estimated by line-probe assay
  19. How Low is Low Volume of Cerebrospinal Fluid from Suspected Cases of Tuberculous Meningitis to Refuse Acceptance in the TB Laboratory? MGIT-960 vs. Molecular Tests: Author’s Reply
  20. Instant Diagnosis Using Raman Spectroscopy and Generative Adversarial Networks: A Blood‐Based Study on Seasonal Flu, COVID‐19, and Dengue
  21. How Low is Low Volume of Cerebrospinal Fluid from Suspected Cases of Tuberculous Meningitis to Refuse Acceptance in the TB Laboratory? Authors’ Reply
  22. Discordance in genotypic and phenotypic drug susceptibility results: time to reconsider critical concentration of rifampicin
  23. Quantitative Image Sensing of Tuberculosis Biomarkers Using Rapid Diagnostic Test Kit
  24. How Low is Low Volume of Cerebrospinal Fluid from Suspected Cases of Tuberculous Meningitis to Refuse Acceptance in the TB Laboratory?
  25. Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data
  26. Possibility of re-purposing antifungal drugs posaconazole & isavuconazole against promastigote form of Leishmania major
  27. Recent improvements in starch films with cellulose and its derivatives–A review
  28. Antimicrobial Susceptibility of Uropathogenic <em>Escherichia coli</em> with Analysis of Impact of Socio-Economic Factors in Low, Medium and High-Income Countries
  29. Bronchoalveolar Lavage Xpert MTB/RIF Assay for Rapid Diagnosis of Smear Negative Pulmonary Tuberculosis in Children
  30. Discordance in Genotypic and Phenotypic anti-tuberculosis drug susceptibility results: time to reconsider critical concentration
  31. A new era for Journal of Laboratory Physicians
  32. Regional variations in antimicrobial susceptibility of community-acquired uropathogenic Escherichia coli in India: Findings of a multicentric study highlighting the importance of local antibiograms
  33. Sensitivity and specificity of newly generated monoclonal antibodies to detect novel antigens of Mycobacterium tuberculosis for the diagnosis of all forms of tuberculosis
  34. Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis—An ESGMYC collaborative study
  35. A multicentre, double-blind, placebo-controlled randomized trial of Mycobacterium w in critically ill patients with COVID-19 (ARMY-2)
  36. End Tuberculosis: Challenges and Opportunities
  37. Klebsiella Pneumoniae Community Acquired UTI: A Multicentric Study Highlights Significant Regional Variations in Antimicrobial Susceptibility Across India
  38. Early Trends to Show the Efficacy of Cordyceps militaris in Mild to Moderate COVID Inflammation
  39. Maiden Impact Factor to Journal of Laboratory Physicians: An Encouragement for Editors and Authors
  40. Pulmonary Tuberculosis in Severely Malnourished Children Admitted to Nutrition Rehabilitation Centers: A Multicenter Study
  41. Invasive mixed fungal disease after covid-19: A series of seven cases
  42. Molecular Identification of Non-tuberculous Mycobacteria in Suspected Tuberculosis Cases in Central India
  43. Microsporidia in HIV-Positive and HIV-Negative Pediatric Patients with Diarrhea at a Tertiary Care Hospital
  44. Deworm the World Initiative: How much Progress India has Made?
  45. Effects of Mitigation and Control Policies in Realistic Epidemic Models Accounting for Household Transmission Dynamics
  46. Antimicrobial Susceptibility Profile of Community-Acquired Uropathogenic Escherichia Coli Across India: A Multicentric Study Promoting Diagnostic Stewardship in the Management of UTI
  47. Combating COVID-19 by employing machine learning predictions and projections
  48. Diagnosis of tuberculous pleural effusion in a tertiary care hospital of central India: The role of xpert Mycobacterium tuberculosis/rifampicin
  49. Evaluation of Xpert MTB/RIF Assay on Stool Samples for the Diagnosis of Pulmonary Tuberculosis among the Pediatric Population
  50. Diagnostic Performance of Multiplex PCR for Detection of Mycobacterium tuberculosis Complex in Presumptive Pulmonary Tuberculosis Patients and Its Utility in Smear Negative Specimens
  51. A comparative analysis of molecular genotypes of Mycobacterium tuberculosis isolates from HIV-positive and HIV-negative patients
  52. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis
  53. Assessment of prescribing pattern of drugs and completeness of prescriptions as per the World Health Organization prescribing indicators in various Indian tertiary care centers
  54. The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study
  55. Organ Involvement in COVID-19: A Molecular Investigation of Autopsied Patients
  56. Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study
  57. TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies
  58. The role of prisons in disseminating tuberculosis in Brazil: A genomic epidemiology study
  59. Clinical, Virological, and Pathological Profile of Patients Who Died of COVID-19: An Autopsy-Based Study From India
  60. The effect of incarceration on TB treatment outcomes
  61. Molecular Detection of Airborne Mycobacterium tuberculosis in South African High Schools
  62. Snapshot of Mycobacterium tuberculosis Phylogenetics from an Indian State of Arunachal Pradesh Bordering China
  63. Assessment of risk factors and outcome of early versus late cytomegalovirus infection infection in living-related D+/R + renal allograft recipients
  64. Role of the gut microbiome and probiotics for prevention and management of tuberculosis
  65. Snapshot of <em>Mycobacterium tuberculosis</em> Phylogenetics from an Indian State of Arunachal Pradesh Bordering China
  66. Relative Consolidation of the Kappa Variant Pre-Dates the Massive Second Wave of COVID-19 in India
  67. Comparative analysis of the diagnostic performance of five commercial COVID-19 qRT PCR kits used in India
  68. Pooling Sputum Samples for Efficient Mass Tuberculosis Screening in Prisons
  69. Mycobacterium tuberculosis-Specific T Cell Functional, Memory, and Activation Profiles in QuantiFERON-Reverters Are Consistent With Controlled Infection
  70. Heterogeneous patterns of COVID-19 transmission in an Urban set up – sero-epidemiological survey data from Ujjain, Madhya Pradesh (a central Indian city)
  71. Mucormycosis after COVID-19 in a patient with diabetes
  72. Profiles of Volatile Biomarkers Detect Tuberculosis from Skin
  73. Testing of four-sample pools offers resource optimization without compromising diagnostic performance of real time reverse transcriptase-PCR assay for COVID-19
  74. Incidence and prevalence of tuberculosis in incarcerated populations: a systematic review and meta-analysis
  75. The escalating tuberculosis crisis in central and South American prisons
  76. Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
  77. A randomised trial of Mycobacterium w in critically ill patients with COVID-19: ARMY-1
  78. Local and Travel-Associated Transmission of Tuberculosis at Central Western Border of Brazil, 2014–2017
  79. Blood-based host biomarker diagnostics in active case finding for pulmonary tuberculosis: A diagnostic case-control study
  80. Pulmonary infections after renal transplantation: a prospective study from a tropical country
  81. Tracking the Emergence of Azithromycin Resistance in Multiple Genotypes of Typhoidal Salmonella
  82. Blood-based host biomarker diagnostics in active case finding for pulmonary tuberculosis: a diagnostic case-control study
  83. The world health organization collaborating center for emergency and trauma (WHO-CCET) in South East Asia, the world academic council of emergency medicine (WACEM), and The American college of academic international medicine (ACAIM) 2021 framework for ...
  84. Profiles of Volatile Biomarkers Detect Tuberculosis from Skin
  85. Increased incarceration rates drive growing tuberculosis burden in prisons and jeopardize overall tuberculosis control in Paraguay
  86. Pan-genome analysis of Mycobacterium tuberculosis identifies accessory genome sequences deleted in modern Beijing lineage
  87. Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
  88. Proinflammatory IgG Fc structures in patients with severe COVID-19
  89. Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide
  90. A Cluster-based, Spatial-sampling Method for Assessing Household Healthcare Utilization Patterns in Resource-limited Settings
  91. Antibiotic Use Prior to Hospital Presentation Among Individuals With Suspected Enteric Fever in Nepal, Bangladesh, and Pakistan
  92. Antimicrobial Resistance in Typhoidal Salmonella: Surveillance for Enteric Fever in Asia Project, 2016–2019
  93. Burden of Culture Confirmed Enteric Fever Cases in Karachi, Pakistan: Surveillance For Enteric Fever in Asia Project (SEAP), 2016–2019
  94. Burden of Ileal Perforations Among Surgical Patients Admitted in Tertiary Care Hospitals of Three Asian countries: Surveillance of Enteric Fever in Asia Project (SEAP), September 2016–September 2019
  95. Diagnostic Value of Clinical Features to Distinguish Enteric Fever From Other Febrile Illnesses in Bangladesh, Nepal, and Pakistan
  96. Healthcare Utilization Patterns for Acute Febrile Illness in Bangladesh, Nepal, and Pakistan: Results from the Surveillance for Enteric Fever in Asia Project
  97. Hospitalization of Pediatric Enteric Fever Cases, Dhaka, Bangladesh, 2017–2019: Incidence and Risk Factors
  98. Illness Severity and Outcomes Among Enteric Fever Cases From Bangladesh, Nepal, and Pakistan: Data From the Surveillance for Enteric Fever in Asia Project, 2016–2019
  99. Spatial Heterogeneity of Enteric Fever in 2 Diverse Communities in Nepal
  100. Typhoid and Paratyphoid Cost of Illness in Nepal: Patient and Health Facility Costs From the Surveillance for Enteric Fever in Asia Project II
  101. Utilization of Blood Culture in South Asia for the Diagnosis and Treatment of Febrile Illness
  102. Mass Drug Administration (MDA) for Lymphatic Filariasis Elimination in Uttar Pradesh, India: Issues, Gaps & Challenges
  103. Evaluation of pooled sample analysis strategy in expediting case detection in areas with emerging outbreaks of COVID-19: A pilot study
  104. Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch Vaccines designed by reverse epitomics approach, shows potential to cover large ethnically distributed human population worldwide
  105. Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development
  106. Genomic variant-identification methods may alter Mycobacterium tuberculosis transmission inferences
  107. Environmental Surveillance as a Tool for Identifying High-risk Settings for Typhoid Transmission
  108. The Surveillance for Enteric Fever in Asia Project (SEAP), Severe Typhoid Fever Surveillance in Africa (SETA), Surveillance of Enteric Fever in India (SEFI), and Strategic Typhoid Alliance Across Africa and Asia (STRATAA) Population-based Enteric Fever...
  109. Clinical Validation of a Deep Learning Algorithm for Detection of Pneumonia on Chest Radiographs in Emergency Department Patients with Acute Febrile Respiratory Illness
  110. Evaluation of a Rapid Point-of-Care Multiplex Immunochromatographic Assay for the Diagnosis of Enteric Fever
  111. Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data
  112. Rapid Antibody-based Tests for the Diagnosis of COVID-19: A Bigger Epidemic of Unscientific Practices
  113. Oral swab testing by Xpert® MTB/RIF Ultra for mass tuberculosis screening in prisons
  114. Seasonal drivers of tuberculosis: evidence from over 100 years of notifications in Cape Town
  115. Performance of Genotype MTBDRsl V2.0 over the Genotype MTBDRsl V1 for detection of second line drug resistance: An Indian perspective
  116. Epidemiology of TORCH Infections and Understanding the Serology in Their Diagnosis
  117. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis
  118. Trehalose limits opportunistic mycobacterial survival during HIV co-infection by reversing HIV-mediated autophagy block
  119. Yield, Efficiency, and Costs of Mass Screening Algorithms for Tuberculosis in Brazilian Prisons
  120. Cost-effectiveness of a Pharmacogenomic Test for Stratified Isoniazid Dosing in Treatment of Active Tuberculosis
  121. COVID-19 blind spots: A consensus statement on the importance of competent political leadership and the need for public health cognizance
  122. Differential seminal plasma proteome signatures of acute lymphoblastic leukemia survivors
  123. Raman spectroscopy reveals distinct differences between two closely related bacterial strains, Mycobacterium indicus pranii and Mycobacterium intracellulare
  124. Molecular mechanism of azithromycin resistance among typhoidal Salmonella strains in Bangladesh identified through passive pediatric surveillance
  125. How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever in Africa Programs Contribute to the Introduction of Typhoid Conjugate Vaccines?
  126. Clinical evaluation for morbidity associated with soil-transmitted helminth infection in school-age children on Pemba Island, Tanzania
  127. Human Epididymis Protein 4 Quantification and Interaction Network Analysis in Seminal Plasma
  128. Establishing national centre for point-of-care technology for 'Swasth Bharat, Samridh Bharat'
  129. Multiplex PCR assay for simultaneous detection and differentiation of Entamoeba histolytica, Giardia lamblia, and Salmonella spp. in the municipality-supplied drinking water
  130. Antibacterial mass drug administration for child mortality reduction: Opportunities, concerns, and possible next steps
  131. Ageing associated proteomic variations in seminal plasma of Indian men
  132. Comparative accuracy of typhoid diagnostic tools: A Bayesian latent-class network analysis
  133. Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategies
  134. The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017
  135. Epidemiology of Typhoid and Paratyphoid: Implications for Vaccine Policy
  136. Understanding lipidomic basis of iron limitation induced chemosensitization of drug-resistant Mycobacterium tuberculosis
  137. Improving Tuberculosis Case Finding in Persons Living with Advanced HIV through New Diagnostic Algorithms
  138. Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings
  139. Whole-Genome Sequencing of Two Extensively Drug-Resistant Mycobacterium tuberculosis Isolates from India
  140. Proteomic analyses reveal lower expression of TEX40 and ATP6V0A2 proteins related to calcium ion entry and acrosomal acidification in asthenozoospermic males
  141. Cutaneous leishmaniasis in Bikaner, India: Clinicoepidemiological profile; parasite identification using conventional, molecular methods and CL Detect™ rapid test, a new Food and Drug Administration-approved test
  142. Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study
  143. Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting
  144. Drivers of Seasonal Variation in Tuberculosis Incidence
  145. Assessing the Risk of Vaccine-derived Outbreaks After Reintroduction of Oral Poliovirus Vaccine in Postcessation Settings
  146. Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response
  147. Extensively Drug-Resistant Typhoid — Are Conjugate Vaccines Arriving Just in Time?
  148. Phenotyping antibiotic resistance with single-cell resolution for the detection of heteroresistance
  149. Integrating Facility-Based Surveillance With Healthcare Utilization Surveys to Estimate Enteric Fever Incidence: Methods and Challenges
  150. Investigating spillover of multidrug-resistant tuberculosis from a prison: a spatial and molecular epidemiological analysis
  151. Invasive Pomacea snails as important intermediate hosts of Angiostrongylus cantonensis in Laos, Cambodia and Vietnam: Implications for outbreaks of eosinophilic meningitis
  152. Seroprevalence of HSV-1 and 2 in HIV-infected males with and without GUD: Study from a tertiary care setting of India
  153. Investigations into Isoniazid Treated Mycobacterium tuberculosis by Electrospray Mass Spectrometry Reveals New Insights into Its Lipid Composition
  154. Association of gyrA and rrs gene mutations detected by MTBDRsl V1 on Mycobacterium tuberculosis strains of diverse genetic background from India
  155. Deworming in pre-school age children: A global empirical analysis of health outcomes
  156. Suicide in Brazilian indigenous communities: clustering of cases in children and adolescents by household
  157. Schistosoma haematobium Egg Excretion does not Increase after Exercise: Implications for Diagnostic Testing
  158. Comparison of Strategies and Incidence Thresholds for Vi Conjugate Vaccines Against Typhoid Fever: A Cost-effectiveness Modeling Study
  159. Genetic Clustering of Tuberculosis in an Indigenous Community of Brazil
  160. Serum vitamin D levels and risk of prevalent tuberculosis, incident tuberculosis and tuberculin skin test conversion among prisoners
  161. Impact and cost-effectiveness of snail control to achieve disease control targets for schistosomiasis
  162. Tropidia Curculioides: Secondary metabolites and derivatives with antimycobacterial and leishmanicidal activity
  163. Diagnostic algorithm for low-volume CSF samples in tuberculous meningitis
  164. Induction of autophagy by trehalose limits opportunistic mycobacterial infections in HIV-infected macrophages
  165. Evaluation of anti-leishmanial and antibacterial activity of <i>Waldheimia tomentosa</i> (Asteraceae), and chemical profiling of the most bioactive fraction
  166. Drivers of Tuberculosis Transmission
  167. Identification of Novel Serodiagnostic Signatures of Typhoid Fever Using a Salmonella Proteome Array
  168. Comparative lipidomics of drug sensitive and resistant Mycobacterium tuberculosis reveals altered lipid imprints
  169. Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection
  170. Current use and acceptability of novel diagnostic tests for active tuberculosis: a worldwide survey
  171. Diagnostic usefulness of Xpert MTB/RIF assay for detection of tuberculous meningitis using cerebrospinal fluid
  172. Evaluation of antimycobacterial, leishmanicidal and antibacterial activity of three medicinal orchids of Arunachal Pradesh, India
  173. Mobile phone and handheld microscopes for public health applications
  174. Parasitic Infections in Pediatric Population of India: Epidemiology, Diagnosis, and Strategies for Prevention
  175. Eosinophilic Meningitis Caused by Angiostrongylus cantonensis
  176. Mobile-phone and handheld microscopy for neglected tropical diseases
  177. Fosfomycin for the treatment of drug-resistant urinary tract infections: potential of an old drug not explored fully
  178. Visceral Leishmaniasis in Children: Diagnosis, Treatment, and Prevention
  179. Evaluation of a Mobile Phone-Based Microscope for Screening of Schistosoma haematobium Infection in Rural Ghana
  180. Determinants of severe dehydration from diarrheal disease at hospital presentation: Evidence from 22 years of admissions in Bangladesh
  181. Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study
  182. Evaluation of 5 Novel protein biomarkers for the rapid diagnosis of pulmonary and extra-pulmonary tuberculosis: preliminary results
  183. Increase in Tuberculosis Cases among Prisoners, Brazil, 2009–20141
  184. A call to strengthen the global strategy against schistosomiasis and soil-transmitted helminthiasis: the time is now
  185. Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
  186. Evaluation of a Smartphone Decision-Support Tool for Diarrheal Disease Management in a Resource-Limited Setting
  187. Poor Validity of Noninvasive Hemoglobin Measurements by Pulse Oximetry Compared with Conventional Absorptiometry in Children in Côte d'Ivoire
  188. Convergence of Minds: For Better Patient Outcome in Intensive Care Unit Infections
  189. Human Spermatozoa Quantitative Proteomic Signature Classifies Normo- and Asthenozoospermia
  190. The benefits of mass deworming on health outcomes: new evidence synthesis, the debate persists
  191. What puts them at risk? A cross-sectional case–control survey of demographic profile and sexual behavior of patients with sexually transmitted infections at a tertiary care center in North India
  192. BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcome
  193. Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis sensitive and resistant Beijing type from a patient with pulmonary tuberculosis
  194. Development of rapid immuno-diagnostic test for the early detection of tuberculosis
  195. Predominance of Beijing lineage among pre-extensively drug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis: A tertiary care center experience
  196. Evaluation of Malaria Diagnoses Using a Handheld Light Microscope in a Community-Based Setting in Rural Côte d'Ivoire
  197. Impact of mass-screening on tuberculosis incidence in a prospective cohort of Brazilian prisoners
  198. Advances in diagnosis, treatment, and prevention of invasive Salmonella infections
  199. Assessment of global guidelines for preventive chemotherapy against schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study
  200. Evaluation of a Urine Pooling Strategy for the Rapid and Cost-Efficient Prevalence Classification of Schistosomiasis
  201. High prevalence of primary drug resistance in children with intrathoracic tuberculosis in India
  202. Improving helminth treatment access: costs and opportunities
  203. Accuracy of Mobile Phone and Handheld Light Microscopy for the Diagnosis of Schistosomiasis and Intestinal Protozoa Infections in Côte d’Ivoire
  204. Possibilities and challenges for developing a successful vaccine for leishmaniasis
  205. Field-testing of a cost-effective mobile-phone based microscope for screening of Schistosoma haematobium infection (Conference Presentation)
  206. Cost-effectiveness of community-wide treatment for helminthiasis – Authors' reply
  207. N-Glycoproteomics of Human Seminal Plasma Glycoproteins
  208. Diagnosis of Opisthorchis viverrini Infection with Handheld Microscopy in Lao People's Democratic Republic
  209. Approaching a diagnostic point-of-care test for pediatric tuberculosis through evaluation of immune biomarkers across the clinical disease spectrum
  210. Human herpesviruses as copathogens of HIV infection, Their role in HIV transmission, and disease progression
  211. Community acquired enterococcal urinary tract infections and antibiotic resistance profile in North India
  212. Congenital toxoplasmosis: Clinical features, outcomes, treatment, and prevention
  213. Bihar’s Pioneering School-Based Deworming Programme: Lessons Learned in Deworming over 17 Million Indian School-Age Children in One Sustainable Campaign
  214. Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia—an observational cohort study
  215. A Cross-Sectional Survey of HIV Testing and Prevalence in Twelve Brazilian Correctional Facilities
  216. The Impact of Ventilation and Early Diagnosis on Tuberculosis Transmission in Brazilian Prisons
  217. Performance of Four Transport and Storage Systems for Molecular Detection of Multidrug-Resistant Tuberculosis
  218. Comparison of community-wide, integrated mass drug administration strategies for schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study
  219. Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis
  220. Performance of Xpert MTB/RIF Assay in Diagnosis of Pleural Tuberculosis by Use of Pleural Fluid Samples
  221. Changes to Initial Postexposure Prophylaxis Regimens Between the Emergency Department and Clinic
  222. Is a Cholera Outbreak Preventable in Post-earthquake Nepal?
  223. Genetic diversity and drug susceptibility profile of Mycobacterium tuberculosis isolated from different regions of India
  224. De Novo Whole-Genome Sequence and Annotation of a Leishmania Strain Isolated from a Case of Post-Kala-Azar Dermal Leishmaniasis
  225. Disseminated Mycobacterium avium Complex Infection in a Child with Partial Dominant Interferon Gamma Receptor 1 Deficiency in India
  226. Diagnosis of Schistosoma haematobium Infection with a Mobile Phone-Mounted Foldscope and a Reversed-Lens CellScope in Ghana
  227. Towards sustainable public health surveillance for enteric fever
  228. Diagnostics for invasive Salmonella infections: Current challenges and future directions
  229. The Epidemiology of Soil-Transmitted Helminths in Bihar State, India
  230. Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India
  231. Molecular epidemiology and evolutionary genetics of Mycobacterium tuberculosis isolated from different parts of India
  232. Prisons as Reservoir for Community Transmission of Tuberculosis, Brazil
  233. The Dynamics of QuantiFERON-TB Gold In-Tube Conversion and Reversion in a Cohort of South African Adolescents
  234. Treating multidrug-resistant tuberculosis in community settings: a wise investment
  235. Active and latent tuberculosis in Brazilian correctional facilities: a cross-sectional study
  236. Challenges in tuberculosis diagnosis and management: Recommendations of the expert panel
  237. Can establishment of human microbiome be customized after birth with local traditions of first feed and intimate kissing?
  238. Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant
  239. Quantitative Evaluation of a Handheld Light Microscope for Field Diagnosis of Soil-Transmitted Helminth Infection
  240. Changing trends in the epidemiology, clinical presentation, and diagnosis of Leishmania–HIV co-infection in India
  241. Is Xpert MTB/RIF assay in gastric lavage aspirate useful for diagnosis of smear-negative childhood pulmonary tuberculosis?
  242. Loop-mediated isothermal amplification assay for rapid and sensitive diagnosis of tuberculosis
  243. Seroprevalence and Determinants of Kaposi Sarcoma-Associated Human Herpesvirus 8 in Indian HIV-Infected Males
  244. Isoniazid preventive therapy in medium-incidence settings: the price is right
  245. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial
  246. Structural and Binding Studies of SAP‐1 Protein With Heparin
  247. Ultra–Low-Cost Urine Filtration for Schistosoma haematobium Diagnosis: A Proof-of-Concept Study
  248. Quantification of Shared Air: A Social and Environmental Determinant of Airborne Disease Transmission
  249. Reply to “Molecular Diagnosis of Rifampin-Monoresistant Tuberculosis in Indian Patients: Problems with a Discordance Analysis”
  250. The Importance of Implementation Strategy in Scaling Up Xpert MTB/RIF for Diagnosis of Tuberculosis in the Indian Health-Care System: A Transmission Model
  251. A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis
  252. A Toolbox for Tuberculosis (TB) Diagnosis: An Indian Multi-Centric Study (2006-2008); Evaluation of Serological Assays Based on PGL-Tb1 and ESAT-6/CFP10 Antigens for TB Diagnosis
  253. Evaluation of portable microscopic devices for the diagnosis of Schistosoma and soil-transmitted helminth infection
  254. Patient Attrition Between the Emergency Department and Clinic Among Individuals Presenting for HIV Nonoccupational Postexposure Prophylaxis
  255. Timing of Tuberculosis Transmission and the Impact of Household Contact Tracing. An Agent-based Simulation Model
  256. Serologic Prevalence of Toxoplasma gondii in Indian Women of Child Bearing Age and Effects of Social and Environmental Factors
  257. Comparison of Xpert MTB/RIF with Line Probe Assay for Detection of Rifampin-Monoresistant Mycobacterium tuberculosis
  258. Clinical and molecular epidemiology of beta-hemolytic streptococcal infections in India
  259. Integrating Social Contact and Environmental Data in Evaluating Tuberculosis Transmission in a South African Township
  260. High prevalence of non-tuberculous mycobacterial disease among non-HIV infected individuals in a TB endemic country – experience from a tertiary center in Delhi, India
  261. Heparin binding carboxypeptidase E protein exhibits antibacterial activity in human semen
  262. Correlation of plasma anti-tuberculosis drug levels with subsequent development of hepatotoxicity
  263. Deciphering the sequential events during in vivo acquisition of drug resistance in Mycobacterium tuberculosis
  264. High degree of multi-drug resistance and hetero-resistance in pulmonary TB patients from Punjab state of India
  265. Comparison of an in-house multiplex PCR with two commercial immuno-chromatographic tests for rapid identification and differentiation of MTB from NTM isolates
  266. Commentary
  267. X-linked hyper-igm syndrome with bronchiectasis
  268. Ambulatory Gastric Lavages Provide Better Yields of Mycobacterium tuberculosis Than Induced Sputum in Children With Intrathoracic Tuberculosis
  269. Studies on the interactions of SAP-1 (an N-terminal truncated form of cystatin S) with its binding partners by CD-spectroscopic and molecular docking methods
  270. Role of the QuantiFERON®-TB Gold In-Tube test in the diagnosis of intrathoracic childhood tuberculosis
  271. Effect of micronutrient deficiency on QuantiFERON-TB Gold In-Tube test and tuberculin skin test in diagnosis of childhood intrathoracic tuberculosis
  272. Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death
  273. Hepatitis A and E in Potable Water: A Threat to Health
  274. A Toolbox for Tuberculosis (TB) Diagnosis: An Indian Multicentric Study (2006–2008). Evaluation of QuantiFERON-TB Gold in Tube for TB Diagnosis
  275. Isolated tuberculous liver abscess in a 3-year-old immunocompetent child
  276. Three low molecular weight cysteine proteinase inhibitors of human seminal fluid: Purification and enzyme kinetic properties
  277. Incidence and Prevalence of Tuberculosis among Household Contacts of Pulmonary Tuberculosis Patients in a Peri-Urban Population of South Delhi, India
  278. Evaluation of an Electricity-free, Culture-based Approach for Detecting Typhoidal Salmonella Bacteremia during Enteric Fever in a High Burden, Resource-limited Setting
  279. Challenges in Evaluating the Cost-effectiveness of New Diagnostic Tests for HIV-Associated Tuberculosis
  280. Genetic heterogeneity revealed by sequence analysis of Mycobacterium tuberculosis isolates from extra-pulmonary tuberculosis patients
  281. Anti-mycobacterial activity of plumericin and isoplumericin against MDR Mycobacterium tuberculosis
  282. Pre–Antiretroviral Therapy Plasma Levels of CCL2 May Aid in the Prediction of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in HIV Patients After They Commence Antiretroviral Therapy
  283. Mobile Phone Microscopy for the Diagnosis of Soil-Transmitted Helminth Infections: A Proof-of-Concept Study
  284. Population deworming every 6 months with albendazole in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial
  285. Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial
  286. Does Neutralization of Gastric Aspirates from Children with Suspected Intrathoracic Tuberculosis Affect Mycobacterial Yields on MGIT Culture?
  287. Heparin and Heparin Binding Proteins: Potential Relevance to Reproductive Physiology
  288. Is Passive Diagnosis Enough?
  289. Modeling the Role of Public Transportation in Sustaining Tuberculosis Transmission in South Africa
  290. Animal Reservoirs of Visceral Leishmaniasis in India
  291. Aggregation analysis of Con A binding proteins of human seminal plasma: A dynamic light scattering study
  292. Pure Red Cell Aplasia in a Three-Months-Old Infant Possibly Secondary to Cytomegalo Virus Infection
  293. Isolated tuberculous liver abscess in immunocompetent children – Report of two cases
  294. Multidrug resistance in bacteria: A serious patient safety challenge for India
  295. Molecular characterization of Mycobacterium tuberculosis isolates from North Indian patients with extrapulmonary tuberculosis
  296. Diagnostic performance of commercially available enzyme-linked immunosorbent assay kit in the diagnosis of extrapulmonary tuberculosis
  297. The Search for a Genetic Factor Associating with Immune Restoration Disease in HIV Patients Co-Infected withMycobacterium tuberculosis
  298. Interaction analysis identifies semenogelin I fragments as new binding partners of PIP in human seminal plasma
  299. Diagnosis of influenza from lower respiratory tract sampling after negative upper respiratory tract sampling
  300. The Chennai declaration: A roadmap to tackle the challenge of antimicrobial resistance
  301. Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their in vitro drug susceptibility pattern
  302. Chemotherapy of Leishmaniasis: Past, Present and Future
  303. Human Epididymis Protein-4 (HE-4): A Novel Cross-Class Protease Inhibitor
  304. Disseminated Tuberculosis Caused by a Rare and Multidrug Resistant “Beijing” Genotype of Mycobacterium tuberculosis
  305. Short Communication: Plasma Levels of Vitamin D in HIV Patients Initiating Antiretroviral Therapy Do Not Predict Immune Restoration Disease Associated with Mycobacterium tuberculosis
  306. Catheter-related bacteremia due to M. chelonae in an immunocompromised patient: An emerging nosocomial pathogen
  307. Usefulness of multiplex PCR in the diagnosis of genital tuberculosis in females with infertility
  308. HIV‐1 Imposes Rigidity on Blood and Semen Cytokine Networks
  309. AIDS associated tuberculosis: A catastrophic collision to evade the host immune system
  310. A Toolbox for Tuberculosis Diagnosis: An Indian Multicentric Study (2006-2008): Microbiological Results
  311. Simple questionnaire and urine reagent strips compared to microscopy for the diagnosis of Schistosoma haematobium in a community in northern Ghana
  312. Poor Performance of Serological Tests in the Diagnosis of Pulmonary Tuberculosis: Evidence from a Contact Tracing Field Study
  313. Kinetic and Structural Studies on the Interactions of Heparin and Proteins of Human Seminal Plasma using Surface Plasmon Resonance
  314. Quantification studies in human seminal plasma samples identify prolactin inducible protein as a plausible marker of azoospermia
  315. Projecting the Benefits of Antiretroviral Therapy for HIV Prevention: The Impact of Population Mobility and Linkage to Care
  316. The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy
  317. Differential proteomics of human seminal plasma: A potential target for searching male infertility marker proteins
  318. Human serum albumin as a new interacting partner of prolactin inducible protein in human seminal plasma
  319. Risk of Progression to Active Tuberculosis Following Reinfection With Mycobacterium tuberculosis
  320. Laboratory evaluation of three regimens of treatment of chronic hepatitis B: Tenofovir, entecavir and combination of lamivudine and adefovir
  321. Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-Commercial Assays: Part 2: Nitrate Reductase Assay v1.3.12
  322. Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-Commercial Assays: Part 1: Microscopic Observation Drug Susceptibility Assay v2.4.12
  323. Rapid Identification and Drug Susceptibility Testing of Mycobacterium tuberculosis: Standard Operating Procedure for Non-Commercial Assays: Part 3: Colorimetric Redox Indicator Assay v1.3.12
  324. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting
  325. Social and News Media Enable Estimation of Epidemiological Patterns Early in the 2010 Haitian Cholera Outbreak
  326. Mycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia
  327. Semen of HIV-1–Infected Individuals: Local Shedding of Herpesviruses and Reprogrammed Cytokine Network
  328. Post‐kala‐azar dermal leishmaniasis: recent developments
  329. Pandemic H1N1 Influenza Infection in Adult Transplant Recipients
  330. Tuberculosis and HIV Co-Infection
  331. HIV-1 and 2009 H1N1 Influenza A in Adults
  332. Evaluation of small-subunit rRNA touchdown polymerase chain reaction for direct detection of Entamoeba histolytica in human pus samples from patients with amoebic liver abscess
  333. Transmission dynamics and control of cholera in Haiti: an epidemic model
  334. Purification and characterization of a native zinc‐binding high molecular weight multiprotein complex from human seminal plasma
  335. Chapter-05 Mycobacterium Tuberculosis
  336. Chapter-06 Nontuberculous Mycobacteria
  337. Current scenario of control of malaria
  338. Chapter-10 Avidity-testing to Pinpoint Timing of Maternal TORCH Infections during Pregnancy
  339. Chapter-18 Laboratory Techniques for Prenatal Diagnosis of Maternal-fetal TORCH Infections
  340. Journal of Laboratory Physicians (JLP): Success story despite many challenges
  341. Mycobacterium avium subspecies paratuberculosis and crohn′s regional ileitis: How strong is association?
  342. Antiparasitic activity of plumericin & isoplumericin isolated from Plumeria bicolor against Leishmania donovani
  343. Prevalence of Hepatitis B Virus Infection in Healthcare Workers of a Tertiary Care Centre in India and Their Vaccination Status
  344. Commercial serological tests for the diagnosis of active tuberculosis in India: Time for introspection
  345. Isolation and Identification of Concanavalin A Binding Glycoproteins from Human Seminal Plasma: A Step Towards Identification of Male Infertility Marker Proteins
  346. Kaposi's Sarcoma-Associated Herpesvirus-Related Solid Lymphoma Involving the Heart and Brain
  347. Predictors of Multidrug- and Extensively Drug-Resistant Tuberculosis in a High HIV Prevalence Community
  348. Mycobacterium tuberculosisevades host immunity by recruiting mesenchymal stem cells
  349. Interaction of Human Seminal Plasma β-Microseminoprotein with Heparin: Binding Mechanism and Thermodynamic Parameters
  350. Urine as an adjunct specimen for the diagnosis of active pulmonary tuberculosis — Author reply
  351. Corrigendum to “Urine as an adjunct specimen for the diagnosis of active pulmonary tuberculosis” [International Journal of Infectious Diseases 13 (2009) 374-379]
  352. Reply to Chang and Leung
  353. Non-Tuberculous Mycobacteria in TB-Endemic Countries: Are We Neglecting the Danger?
  354. Assessment of the N-PCR Assay in Diagnosis of Pleural Tuberculosis: Detection of M.tuberculosis in Pleural Fluid and Sputum Collected in Tandem
  355. Safety of 3 Different Reintroduction Regimens of Antituberculosis Drugs after Development of Antituberculosis Treatment–Induced Hepatotoxicity
  356. Occult Hepatitis B Virus infection in ART-Naive HIV-Infected Patients seen at a Tertiary Care Centre in North India
  357. Genome-wide Analysis of the Host Intracellular Network that Regulates Survival of Mycobacterium tuberculosis
  358. Occult hepatitis B virus infection in ART-naive HIV-infected Indian patients
  359. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India
  360. HIV Coinfection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality
  361. Proteomic analysis of heparin-binding proteins from human seminal plasma: a step towards identification of molecular markers of male fertility
  362. Recovery of Mycobacterium tuberculosis from Sputum Treated with Cetyl Pyridinium Chloride
  363. Acute bilateral vision loss as the presenting feature of subacute sclerosing panencephalitis
  364. Visual Format for Detection of Mycobacterium tuberculosis and M. bovis in Clinical Samples Using Molecular Beacons
  365. Immunogenicity of candidate chimeric DNA vaccine against tuberculosis and leishmaniasis
  366. Multiplex PCR assay for simultaneous detection and differentiation ofMycobacterium tuberculosis,Mycobacterium aviumcomplexes and other Mycobacterial species directly from clinical specimens
  367. Evaluation of anti-leishmanial activity of selected Indian plants known to have antimicrobial properties
  368. Variable-number tandem repeat 3690 polymorphism in Indian clinical isolates of Mycobacterium tuberculosis and its influence on transcription
  369. Averting epidemics of extensively drug-resistant tuberculosis
  370. Urine as an adjunct specimen for the diagnosis of active pulmonary tuberculosis
  371. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis
  372. Chapter-18 Laboratory Techniques for Prenatal Diagnosis of Maternal-Fetal Infections
  373. Chapter-07 Avidity Testing to Pinpoint Timing of Maternal Infections during Pregnancy
  374. Hepatitis B in health care workers: Indian scenario
  375. Progress of science from microscopy to microarrays (Part 1): Diagnosis of parasitic diseases
  376. In-vitro antimycobacterial drug susceptibility testing of non-tubercular mycobacteria by tetrazolium microplate assay
  377. Unusual lymphocytosis with systemic lupus erythematosus
  378. Filtration of Cerebrospinal Fluid Improves Isolation of Mycobacteria
  379. Expression and characterization of a recombinant kinesin antigen from an old Indian strain (DD8) of Leishmania donovani and comparing it with a commercially available antigen from a newly isolated (KE16) strain of L. donovani
  380. Opportunistic pathogens in AIDS: trends, diagnosis and priorities
  381. Kinesin Motor Domain of Leishmania donovani as a Future Vaccine Candidate
  382. Prevalence of mycobacteremia in Indian HIV-infected patients detected by the MB/BacT automated culture system
  383. Role of Horizontal Transmission in Hepatitis B Virus Spread among Household Contacts in North India
  384. Comparative evaluation of FASTPlaque assay with PCR and other conventional in vitro diagnostic methods for the early detection of pulmonary tuberculosis
  385. Chronic diarrhoea in HIV patients: Prevalence of coccidian parasites
  386. Scaling up anti-mycobacterial drug susceptibility testing services in India: It is high time
  387. Multidrug‐Resistant and Extensively Drug‐Resistant Tuberculosis: Implications for the HIV Epidemic and Antiretroviral Therapy Rollout in South Africa
  388. Seroprevalence of HIV in pregnant women in North India: a tertiary care hospital based study
  389. High rate of extensively drug-resistant tuberculosis in Indian AIDS patients
  390. Immune Restoration Syndrome with disseminated Penicillium marneffei and Cytomegalovirus co-infections in an AIDS patient
  391. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study
  392. Surface plasmon resonance studies and biochemical evaluation of a potent peptide inhibitor against cyclooxygenase-2 as an anti-inflammatory agent
  393. Quality of life in lung cancer patients: impact of baseline clinical profile and respiratory status
  394. Chemotherapy of Leishmaniasis: Past, Present and Future
  395. Controlling multidrug-resistant tuberculosis in India
  396. Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India
  397. Novel method for clearing red blood cell debris from BacT/ALERT® blood culture medium for improved microscopic and antimycobacterial drug susceptibility test results
  398. Erratum
  399. Use of Immunoglobulin G Avidity To Determine the Course of Disease in Visceral and Post-Kala-Azar Dermal Leishmaniasis Patients
  400. Leishmania–HIV co-infection: An emerging problem in India
  401. Cloning, expression, and purification of a novel recombinant antigen from Leishmania donovani
  402. Chapter-05 Mycobacterium Tuberculosis
  403. Visceral leishmaniasis—an opportunistic infection in HIV-infected patients - Authors' reply
  404. Tumor Necrosis Factor-α Levels in Patients with HIV with Wasting in South Asia
  405. Visceral leishmaniasis—an opportunistic infection in HIV-infected patients
  406. Applications of molecular methods for Leishmania control
  407. A case of pulmonary Mycobacterium celatum in an Indian AIDS patient
  408. Mucosal leishmaniasis in an Indian AIDS patient
  409. Predicting Kala-Azar Disease Manifestations in Asymptomatic Patients with Latent Leishmania donovani Infection by Detection of Antibody against Recombinant K39 Antigen
  410. Incidence and Prevalence of Toxoplasmosis in Indian Pregnant Women: a Prospective Study
  411. Chapter-13 Laboratory Diagnosis of Congenital Fetal/Neonatal TORCH Infection
  412. Chapter-04 Avidity-testing to Pinpoint Timing of Maternal TORCH Infections During Pregnancy
  413. Challenges and new discoveries in the treatment of leishmaniasis
  414. Food crisis and AIDS: the Indian perspective
  415. Human immunodeficiency virus transmitted through sheep brain anti-rabies vaccination
  416. Down‐Regulation of T Helper 1 Responses to Mycobacterial Antigens Due to Maturation of Dendritic Cells by 10‐kDa Mycobacterium tuberculosis Secretory Antigen
  417. Leishmaniasis: new approaches to disease control
  418. Mother-to-child transmission of hepatitis E virus infection
  419. Recent advances in the diagnosis of leishmaniasis.
  420. Effect of Mycobacterium tuberculosis-Specific 10-Kilodalton Antigen on Macrophage Release of Tumor Necrosis Factor Alpha and Nitric Oxide
  421. Diagnostic and prognostic value of nested polymerase chain reaction in the post-transplant reactivation of cytomegalovirus (CMV) infection
  422. Predicting Kala-Azar Disease Manifestations in Asymptomatic Patients with Latent Leishmania donovani Infection by Detection of Antibody against Recombinant K39 Antigen
  423. Infections and risk factors in entrants to Irish prisons
  424. Nested polymerase chain reaction in the diagnosis of congenital cytomegalovirus infection
  425. Isolation of Free Living Amoebas as a Highly Sensitive Index of Water Contamination
  426. Iodinated Natural Rubber Latex: Preparation, Characterisation & Antibacterial Activity Assessment
  427. Iodinated Natural Rubber Latex: Preparation, Characterisation & Antibacterial Activity Assessment
  428. Hepatitis B, C and Human Immunodeficiency Virus Infections in Multiply-injected Kala-azar Patients in Delhi
  429. Hepatitis B and C viral infections in Indian Kala-Azar patients receiving inj ectable anti-leishmanial drugs: A community-based study
  430. High prevalence of sexually transmitted and blood-borne infections amongst the inmates of a district jail in Northern India
  431. “Plasmodium ovale infection in delhi” published in Indian Journal of Pediatrics Jan–Feb 1999; vol. 66 (1): 143–145
  432. Hookworm Disease Misdiagnosed as Intestinal Lymphoma
  433. Kala-azar-new developments in diagnosis and treatment
  434. Research letter. Sentinel surveillance of Chlamydia Trachomatis in school-going girls vis-a-vis women with secondary infertility
  435. Fever of Unknown Origin: A Prospective Study
  436. Transfusion‐transmitted kala‐azar in India
  437. A single-step immunochromatographic test for the detection of Entamoeba histolytica antigen in stool samples
  438. Diagnostic and Prognostic Value of K39 Recombinant Antigen in Indian Leishmaniasis
  439. Tuberculosis following immunosuppressive treatment after exposure to toxic smoke
  440. High TORCH seroprevalence rate in multiply transfused β thalassemic children in India
  441. Acanthamoeba keratisis
  442. Group B Meningococcal Meningitis in India
  443. Low-Cost Refractometer for Measurement of Protein Concentration and Specific Gravity of Body Fluids
  444. Detection of antigens of Mycobacterium tuberculosis in patients of infertility by monoclonal antibody based sandwiched enzyme linked immunosorbent assay (ELISA)
  445. Transient Isospora belli infection in a normal child
  446. "Pseudo-resistant" malaria in tropical countries
  447. Severe cutaneous mycobacterium chelonei infection following a yellow jacket sting
  448. Family outbreak of scalp phthiriasis
  449. Ketoconazole in the Treatment of Antimony- and Pentamidine-Resistant Kala-Azar
  450. The housefly (Musca domestica) as a carrier of pathogenic microorganisms in a hospital environment
  451. Paramecium Colonizing Urinary Tract of a Patient on Dialysis: A Rare Entity
  452. Urine examination: Its importance in the pediatric medicine
  453. Fungal diarrhoea
  454. Fungal diarrhoea Reply on the comments by Dr Sarman Singh
  455. Laboratory diagnosis of intestinal parasitosis
  456. Ketoconazole in treatment of visceral leishmaniasis
  457. BLOOD-FILMS IN THE DIAGNOSIS OF MALARIA
  458. Contamination of an endoscope due to Trichosporon beigelli
  459. Candidiasis after cimetidine therapy